À propos de FORUS
Direction
Valeurs
Dernières actualités
XPOVIO® Now Funded in British Columbia
FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in British Columbia as of October 1, 2023. Further details on the criteria can be found here, under the MYBSD protocol: Lymphoma & Myeloma (bccancer.bc.ca) We are excited...
XPOVIO® Now Funded in Saskatchewan
FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Saskatchewan as of September 1st. Please see the following link for full funding criteria: Drug Formulary (saskcancer.ca). We are excited about this important milestone for...
XPOVIO® Now Funded in Alberta
FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Alberta as of June 5, 2023. Please see the following link for full funding criteria: AHS Outpatient Cancer Drug Benefit Program 2023-06-05 (albertahealthservices.ca). We are...
NOUS JOINDRE
Adresse postale:
FORUS Therapeutics Inc.
200 North Service Road West, Suite 129
Oakville, Ontario, L6M 2Y1
Téléphone: 1-877-359-9595
Télécopieur: 1-877-359-9590
Soutien aux patients:
Téléphone: 1-833-4YOUPSP (1-833-496-8777)
Télécopieur: 1-833-4YOUFAX (1-833-496-8329)
Support produit:
Téléphone: 1-866-542-7500
Télécopieur: 1-866-542-1100
N’utilisez pas ce formulaire pour signaler des événements indésirables. Les événements indésirables peuvent être signalés à 1-866-542-7500.